Taysha Gene Therapies (TSHA) Times Interest Earned (2020 - 2026)

Taysha Gene Therapies has disclosed Times Interest Earned across 7 years of filings, most recently posting -$4831.8 for Q1 2026.

• Times Interest Earned for Q1 2026 came in at -$4831.8, down 328.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2501.2 (down 159.86% YoY), and the FY2025 annual result was -$1753.9, down 95.61% from the prior year.
• Times Interest Earned came in at -$4831.8 for Q1 2026 at Taysha Gene Therapies, down from -$2358.3 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of -$11.05 in Q3 2023 to a low of -$4831.8 in Q1 2026.
• The 5-year median for Times Interest Earned is -$788.85 (2024), against an average of -$942.25.
• Across the five-year window, Times Interest Earned jumped 83.69% in 2023 and tumbled 9668.19% in 2024, its largest moves.
• Taysha Gene Therapies' Times Interest Earned stood at -$41.35 in 2022, then surged by 44.9% to -$22.79 in 2023, then plunged by 3876.23% to -$906.0 in 2024, then tumbled by 160.3% to -$2358.3 in 2025, then plunged by 104.88% to -$4831.8 in 2026.
• The last three Times Interest Earned figures came in at -$4831.8 (Q1 2026), -$2358.3 (Q4 2025), and -$2268.3 (Q3 2025), per Business Quant data.